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Abstract The Fura-2 method is used to examine a possible
action of 17L-estradiol (E2) on [Ca2+]i of splenic T cells isolated
from female C57BL/10 mice. E2 concentrations between 10 fM
and 10 nM induce a rapid and dose-dependent increase in [Ca2+]i
due to Ca2+ influx and release of Ca2+ from intracellular stores.
Ca2+ influx is mediated by Ca2+ channels which are completely
blockable by Ni2+ and partly by nifedipine. The antiestrogen
tamoxifen does not inhibit the E2-induced rise in [Ca2+]i. Ca2+
influx and Ca2+ release from intracellular stores is also inducible
by plasma membrane impermeable E2 conjugated to BSA. E2-
BSA-FITC binds to the surface of T cells of both the CD4+ and
CD8+ subset. Our data suggest a novel E2-signalling pathway in
T cells which is not mediated through the classical nuclear
estrogen receptor response but rather through putative plasma
membrane receptors for E2.
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1. Introduction
Estrogens, like other steroids, exert their major long-term
e¡ects on cell growth, di¡erentiation, and function through
nuclear estrogen receptors (ER), which belong to the steroid
receptor superfamily, by activating speci¢c estrogen-respon-
sive genes [1^6]. The ER contains several domains for estro-
gen binding, nuclear localization, dimerization, DNA binding,
and transactivation [7]. However, there is now also increasing
evidence for a non-genomic action of steroid hormones in-
cluding estrogens which is not mediated through the classical
nuclear receptor response (for reviews, see e.g. [8,9]). For in-
stance, 17L-estradiol (E2) can induce a fast rise in the cytosolic
free Ca2 concentrations [Ca2]i of di¡erent cell types. This
rise in [Ca2]i may be due to an in£ux of extracellular Ca2 as
in uterine endometrial cells [10], in rat osteoblasts [11], in
LNCaP human prostate cancer cells [12], in intestinal mucosal
cells [13], and/or due to a mobilization of Ca2 from intra-
cellular Ca2 stores as in chicken granulosa cells [14] and rat
osteoblasts [11]. The intracellular Ca2 store involved in this
mechanism is the endoplasmic reticulum since E2 enhances the
formation of inositol 1,4,5-trisphosphate via the activation of
a phospholipase CL2 linked to a pertussis-sensitive G-protein
[11,15].
T cells play a central role in the regulation of immune
responses and thus the outcome of infectious diseases
[16,17]. There is some circumstantial evidence that E2 is able
to a¡ect T cells [16^19]. However, the action of E2 on T cells
is not yet understood. In particular, there is a controversial
debate on whether or not T cells contain ER [17]. The current
evidence indicates that only T cells of the CD8 subset con-
tain classical ER whereas CD4 T cells have no ER [20].
Here, we reveal that T cells of both the CD4 subset and
the CD8 subset possess E2 binding sites on their cell surfaces
and that binding of E2 induces both Ca2 in£ux through Ca2
channels and release of Ca2 from the endoplasmic reticulum.
2. Materials and methods
2.1. Isolation of T cells
Female mice of the inbred strain C57BL/10 were obtained from our
animal facilities. Spleens were aseptically removed and total nucleated
spleen cells were isolated as detailed previously [21]. T cells were then
prepared using the nylon-wool procedure [22]. These contained about
90^95% Thy1 T cells with about 55^60% CD4 T cells and about
35^40% CD8 T cells as routinely examined by FACScan analysis.
2.2. Determination of [Ca2 +]i
[Ca2]i was measured in T cell suspension as detailed previously
[19]. In brief, 107 T cells/ml were loaded with 3 WM Fura-2/acetoxy-
methylester (Amersham, Les Ulis, France) at 37‡C in HEPES bu¡er
[19]. Aliquots of the loaded cells (5U106/ml) were measured at 37‡C
in a quartz cuvette placed in a Hitachi F-2000 spectro£uorometer
after adding reagents under continuous stirring. E2 (17L-estradiol),
E2-BSA (17L-estradiol 6-(O-carboxymethyl)oxime:BSA), nifedipine
and tamoxifen were purchased from Sigma (St. Quentin, Fallavier,
France). Cell suspensions were excited alternatively at 340 nm and
380 nm and the £uorescence was measured at 510 nm. Graphic rep-
resentations of [Ca2]i were computed using the equation
[Ca2]i = 224U(R3Rmin)/(Rmax3R)USf380/Sb380 as previously de-
scribed [23]. Rmin and Rmax were evaluated from measurements using
25 WM digitonin, 4 mM EGTA and Tris base to raise the pH to or
above 8.3 [24].
2.3. Confocal laser scanning microscopy (CLSM)
Intact T cells were diluted to 107 cells/ml in PBS (140 mM NaCl,
2.7 mM KCl, 6.4 mM Na2HPO4W2H2O, 1.4 mM KH2PO4, 0.5 mM
MgCl2W6H2O, 0.9 mM CaCl2, pH 7.2). Aliquots of 150 Wl were cen-
trifuged and the cell pellets labelled with 200 Wl of E2-BSA-FITC
(17L-estradiol 6-(O-carboxymethyl)oxime:BSA-£uorescein isothiocya-
nate conjugate) (1.5U1035 M; Sigma, Deisenhofen, Germany) for 1 h
at room temperature. BSA-FITC was used in corresponding control
experiments. For colocalization analysis, the plasma membrane was
stained for 15 min with ConA-rhodamine (Vector, Burlingame, CA,
USA) at a working dilution of 1:50. After two washes, the cells were
¢xed in 0.5% paraformaldehyde and allowed to adhere onto polyly-
sine-coated glass coverslips for 15 min, which were then rinsed with
PBS. Samples were mounted on microscope slides in a 1:1 (v/v)
mixture of glycerol and Vectashield (Vector) containing 2% (w/v)
1,4-diazabicyclo[2,2,2]octane (DABCO, Merck, Darmstadt, Ger-
many). The specimens were analyzed with a Leica confocal laser scan-
ning microscope unit (Leica Lasertechnik, Heidelberg, Germany)
mounted on a Zeiss IM 35 microscope (Zeiss, Oberkochen, Germany).
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FITC and rhodamine £uorescence were excited by the 488 nm argon
laser line and the 568 nm krypton laser line, respectively. Z-series
optical sections were taken at 0.5 Wm intervals and evaluated using
AVS software (Advanced Visual Systems Inc., Waltham, MA, USA)
on an Indigo 2 Unix workstation (Silicon Graphics Inc., Mountain
View, CA, USA) as described elsewhere [25].
2.4. Flow cytometry
T cells were labelled with E2-BSA-FITC or BSA-FITC as above
and with monoclonal antibody to mouse Ly-2 conjugated with phy-
coerythrin (CD8-PE) (Boehringer, Mannheim, Germany) and anti-
mouse L3T4 PE (CD4-PE) (Becton Dickinson, Heidelberg, Germany)
as described previously [21]. Cells were analyzed in a FACScan (Bec-
ton Dickinson, Sunnyvale, CA, USA) with a sample size of 10 000
cells gated on the basis of forward and side scatter, and the data were
stored and processed using the FACScan software as described pre-
viously [21].
3. Results
E2 induced a rapid increase of [Ca2]i in T cells which al-
ways occurred as a prolonged elevation. These E2 e¡ects were
dose-dependent: concentrations as low as 10 fM E2 induced
an increase by about 15^20 nM Ca2 (Fig. 1A), 0.1 nM E2
raised [Ca2]i by about 30^35 nM (Fig. 1B) and 10 nM E2 by
about 80^90 nM Ca2 (Fig. 1C). The E2-induced increase in
[Ca2]i resulted from two mechanisms: the release of Ca2
from the endoplasmic reticulum and the in£ux of extracellular
Ca2 through the plasma membrane [19]. The Ca2 in£ux is
speci¢c, i.e. it is not a simple di¡usion, but rather it is chan-
nel-mediated. Indeed, the E2-induced Ca2 increase can be
gradually decreased and almost completely inhibited with in-
creasing doses of the speci¢c Ca2 channel blocker Ni2 (Fig.
2A). Moreover, nifedipine, a blocker of L-type voltage-gated
Ca2 channels, reduced the E2-induced Ca2 in£ux by about
50% (Fig. 2B). In contrast, depolarization of T cells with high
K concentrations did not a¡ect the E2-induced Ca2 in£ux
at all (Fig. 2C).
Preincubation of T cells for 2 h with 0.5 WM of the anti-
estrogen tamoxifen did not prevent the increase in [Ca2]i
induced by only 0.1 nM E2 (Fig. 3A). Moreover, a rise in
[Ca2]i could be also induced by E2 conjugated to bovine
serum albumin (E2-BSA), which did not enter the cells (Fig.
3B). Subsequent addition of the same concentration of 100
nM E2-BSA to the same cell suspension resulted in a higher,
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Fig. 1. Action of E2 on [Ca2]i of T cells. Arrows indicate addition of di¡erent E2 concentrations to T cell suspensions.
Fig. 2. E¡ects of di¡erent substances on cytosolic free calcium concentration in T cells. A: T cells were incubated for 5 min with various con-
centrations of Ni2, before adding E2. B: T cells were incubated for 1.5 min with nifedipine, before addition of E2. C: T cells were pretreated
for 1 min with KCl before adding E2.
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i.e. approximately 2^3-fold increase in [Ca2]i. In contrast,
BSA without conjugated E2 had no e¡ect (Fig. 3B). The im-
permeable E2-BSA like unconjugated E2 [19] increased the
[Ca2]i through Ca2 in£ux and release from intracellular
Ca2 stores. Indeed, when extracellular Ca2 was completely
removed by EGTA, E2-BSA was still able to induce a small
increase in [Ca2]i exclusively due to mobilization of intra-
cellular Ca2 (Fig. 3C).
To test the occurrence of putative receptors on the cell sur-
face, we have used the impeded ligand E2-BSA labelled with
FITC in confocal laser scanning microscopy. E2-BSA-FITC
was localized only at the cell surface of T cells (Fig. 4). In
control experiments, BSA-FITC did not result in any £uores-
cence at the cell surface. When the cells were stained with
ConA-rhodamine, a general marker for the plasma mem-
brane, the £uorescence pattern was identical to that observed
with E2-BSA-FITC. FACScan analysis showed that binding
of E2-BSA-FITC occurred on both CD4 T cells and CD8 T
cells (Fig. 5).
The E2-induced rise in [Ca2]i obviously had consequences
for the responsiveness of T cells to antigens. Stimulation of T
cells by the monoclonal anti-CD3 antibody, which binds to
the 25 kDa O chain of the T cell receptor-associated CD3
complex, caused an immediate rise of [Ca2]i in T cells (Fig.
6A). The pro¢le of the [Ca2]i response to anti-CD3 antibody
was modi¢ed when T cells were preincubated with E2 (Fig.
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Fig. 3. Action of E2 on [Ca2]i via non-genomic surface receptors. A: T cells were pretreated with tamoxifen for 4 h before adding E2. B: Ef-
fects of E2 conjugated to BSA (estradiol-BSA), and BSA alone on T cells. C: After removal of external Ca2 by EGTA, estradiol-BSA induces
intracellular Ca2 release in T cells.
Fig. 4. Corresponding confocal optical slices of a T cell incubated with E2-BSA-FITC and ConA-rhodamine. Note the obvious colocalization
of the two di¡erent £uorescences. Bar indicates 2 Wm.
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6B). Speci¢cally, preincubation with 0.1 nM E2 for 180 s
delayed and diminished the slope of the initial [Ca2]i re-
sponse to anti-CD3 antibody without apparently altering the
sustained [Ca2]i plateau phase (Fig. 6A,B).
4. Discussion
This study provides evidence that E2 exerts a direct and
immediate e¡ect on T cells. This action does not follow the
classical nuclear ER response but rather is mediated through
binding of E2 to the cell surface. Indeed, the e¡ect of E2
manifests itself as an increase in [Ca2]i within seconds. Our
data further show that this increase is due to both a speci¢c
in£ux of external Ca2 through Ca2 channels completely
blockable by Ni2, and in part by nifedipine, and a release
of Ca2 from intracellular stores. Internal mobilization of
Ca2 appears to be a general mechanism used by E2 [11,14],
while the type of Ca2 channels involved in the in£ux of
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Fig. 5. Localization of estradiol-BSA-FITC on CD4 T cells and CD8 T cells by £ow cytometry. The cells were simultaneouly labelled with
estradiol-BSA-FITC and CD4-phycoerythrin (PE) or CD8-PE (upper ¢gures). The lower ¢gures show controls: on the left, red and green £uo-
rescence of T cells incubated only with BSA; on the right, T cells incubated with BSA-FITC.
Fig. 6. E¡ects of E2 and anti-CD3 on [Ca2]i of T cells. A: Increase in [Ca2]i by anti-CD3. B: E¡ect of E2 on anti-CD3-induced increase in
[Ca2]i.
W.P.M. Benten et al./FEBS Letters 422 (1998) 349^353352
extracellular Ca2 appears to depend on the cell type: Ni2-
sensitive Ca2 channels in T cells and voltage-gated Ca2
channels as in osteoblasts [11].
An increase in [Ca2]i is also induced by E2-BSA which is
impermeable to the plasma membrane, but acts by the same
mechanisms as E2. This indicates that the plasma membrane
of T cells contains putative receptors for E2. This view is
further substantiated by confocal laser scanning microscopy
showing a £uorescent staining at the cell surface with the
impeded ligand E2-BSA-FITC. This corroborates recent
data obtained in GH3/B6 rat pituitary cells with the same
£uorescent estrogen-BSA conjugate [26]. In addition, our
FACScan analysis reveals E2 binding sites on the surface of
both CD4 T cells and CD8 T cells. Although only T cells of
the CD8 subset contain classical ER [17,20], both T cell
subsets exhibit putative plasma membrane receptors for E2.
Moreover, the antiestrogen tamoxifen, which antagonizes es-
trogen action by inhibiting estradiol-induced activation of
genes containing estrogen-responsive elements in their pro-
moters to various extents [27,28], does not prevent the E2-
induced increase in [Ca2]i in T cells as in other cells
[11,14]. Collectively, our data suggest that the putative plasma
membrane receptors for E2 on T cells are not the classical
genomic ERs.
T cells also possess unconventional androgen receptors [19].
Binding of testosterone to these receptors increases [Ca2]i
only by Ca2 in£ux through Ca2 channels. The present
data indicate that the putative membrane receptors for E2
are not identical to those of testosterone since only E2 is
able to mobilize Ca2 from the endoplasmic reticulum. More-
over, impermeable E2-BSA also mobilizes intracellular Ca2
from endoplasmic reticulum. This suggests that the putative
plasma membrane receptors for E2 on T cells are coupled to
an intracellular signalling pathway, which remains to be elu-
cidated. In this context, it is noteworthy that the multiple
second messenger Ca2 is known to change gene expression
via both Ca2-responsive elements and negative Ca2-respon-
sive elements in gene promoters as well as via Ca2-sensitive
transcription factors [29].
Finally, our data indicate that binding of E2 to the surface
interferes with the responsiveness of T cells to antigenic stim-
ulation with anti-CD3. It remains to be seen in how far this
contributes to E2-sensitive immune responses and outcome of
infectious diseases [15^17].
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